Clinical Trial Update: Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial [NA]

View source ↗

Summary

This document outlines the protocol for a randomized controlled trial evaluating electronic symptom monitoring of patient-reported outcomes in patients with hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Wei Xiaoping | Conditions: Hepatocellular Carcinoma (HCC) | NA | Status: RECRUITING